Get startedLog in
    Picture of Iovance Biotherapeutics logo

    IOVA — Iovance Biotherapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeLarge CapHigh Flyer
    All News

    US FDA approves Replimune's skin cancer drug

    Picture of Iovance Biotherapeutics logoIovance Biotherapeutics
    06/08/2026 21:13
    US FDA approves Replimune's skin cancer drug
    Aug 6 (Reuters) - The U.S. Food and Drug Administration has approved Replimune's REPL.O drug for a difficult-to-treat form of skin cancer, the company said on Thursday, giving the biotech firm its first marketed product after years of regulatory setbacks. 


     (Reporting by Kamal Choudhury and Sneha S K in Bengaluru; Editing by Vijay Kishore)
     ((Kamal.Choudhury@thomsonreuters.com;))

    Recent news on Iovance Biotherapeutics

    See all news